Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: Synthesis, biological evaluation and molecular modeling studies
- 31 July 2008
- journal article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 43 (7), 1469-1477
- https://doi.org/10.1016/j.ejmech.2007.09.020
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3Bioorganic & Medicinal Chemistry Letters, 2006
- CDK/GSK-3 Inhibitors as a New Approach for the Treatment of Proliferative Renal DiseasesDrug News & Perspectives, 2006
- Mammalian cyclin-dependent kinasesTrends in Biochemical Sciences, 2005
- Microwave-assisted Synthesis of Novel Thiazolocarbazoles and Evaluation as Potential Anticancer Agents. Part IIIJournal of Enzyme Inhibition and Medicinal Chemistry, 2004
- Pharmacological inhibitors of glycogen synthase kinase 3Trends in Pharmacological Sciences, 2004
- The glamour and gloom of glycogen synthase kinase-3Trends in Biochemical Sciences, 2004
- Efficient synthesis of thiazoloquinazolinone derivativesTetrahedron Letters, 2003
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Pharmacological inhibitors of cyclin-dependent kinasesTrends in Pharmacological Sciences, 2002
- Synthese und Reaktionen des 4,5‐Dichlor‐1,2,3‐dithiazolium‐chloridsEuropean Journal of Inorganic Chemistry, 1985